Currently our ability to control and manipulate stem cells is limited to the manipulation of growth factors while in culture; however, when removed from culture and injected into animals or patients, we lose this control. This session will evaluate the need for greater stem cell control via stem cell engineering in order to create more potent stem cell therapies.



Objectives:

Outline current challenges in commercializing stem cell therapeutics.

Understand the potential to engineer stem cell products.

Discuss the regulatory and supply issues that would face engineered stem cell therapeutics.